The role of CYLD in canonical and noncanonical NFKB pathway
The role of CYLD in canonical and noncanonical NF-κB pathway. In the canonical NF-κB pathway, NF-κB dimmers such as p65/p50 are maintained in the cytoplasm by interaction with an IκBα protein. The binding of a ligand to a cell-surface receptor activates TAK1 which in turn activates an IKK complex, containing-α, -β, and NEMO, which is responsible for phosphorylation of IKK-β. IKK-β then phosphorylates IκB-α, leading to K48-ubiquitination and degradation of this protein. p65/p50 then freely enters the nucleus to turn on target genes. The noncanonical pathway is largely for the activation of p100/RelB complexes and differs from the classical pathway in that only certain receptor signals, activate this pathway and it proceeds through an IKK complex that contains two IKK-α subunits but not NEMO. In the noncanonical NF-κB pathway, receptor binding leads to activation of the NF-κB-inducing kinase NIK, which phosphorylates and activates an IKK-α complex that in turn phosphorylates IκB domain of p100, leading to its partial proteolysis and liberation of the p52/RelB complex. CYLD blocks canonical NF-κB pathway by the removal of Lys-63 ubiquitinated chains from activated TRAFs, RIP, NEMO, and BCL3.
Publication
Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer. (2011) K. C. Masoumi, et al. J Skin Cancer. 2011;2011:614097. Figure: F2.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | BAFFR, | BAFFR | ncbigene_synonym | TNFRSF13C | 115650 |
| Homo sapiens | Primates | BAFFR,CD40,andLTØR | CD40 | ncbigene_symbol | CD40 | 958 |
| Homo sapiens | Primates | TNFR, | TNFR | ncbigene_synonym | TNFRSF1A | 7132 |
| Homo sapiens | Primates | TRAF2 | TRAF2 | ncbigene_symbol | TRAF2 | 7186 |
| Homo sapiens | Primates | TRAF2 | TRAF2 | ncbigene_synonym | TANK | 10010 |
| Homo sapiens | Primates | TRAF3 | TRAF3 | ncbigene_symbol | TRAF3 | 7187 |
| Homo sapiens | Primates | NIK | NIK | ncbigene_synonym | MAP3K14 | 9020 |
| Homo sapiens | Primates | NIK | NIK | ncbigene_synonym | MAP4K4 | 9448 |
| Homo sapiens | Primates | CYLD | CYLD | ncbigene_symbol | CYLD | 1540 |
| Homo sapiens | Primates | TAB2 | TAB2 | ncbigene_symbol | TAB2 | 23118 |
| Homo sapiens | Primates | NEMO | NEMO | ncbigene_synonym | IKBKG | 8517 |
| Homo sapiens | Primates | (RelB | RELB | ncbigene_symbol | RELB | 5971 |
| Homo sapiens | Primates | ps2) | PS2 | ncbigene_synonym | PSEN2 | 5664 |
| Homo sapiens | Primates | ps2) | PS2 | ncbigene_synonym | TFF1 | 7031 |
| Homo sapiens | Primates | ps2) | PS2 | ncbigene_synonym | TAS2R64P | 338412 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | CUX1 | 1523 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | NFKB2 | 4791 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | OAS3 | 4940 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | PMEL | 6490 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | SART3 | 9733 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | TPX2 | 22974 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | SND1 | 27044 |
| Homo sapiens | Primates | p100 | P100 | ncbigene_synonym | ASCC2 | 84164 |
| Word | Match | MeSH | Name | ChEBI |
|---|
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|